# Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33  Clinical Trials Not Allowed)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** RFA-HL-26-017
- **Status:** posted
- **Opens:** November 22, 2024
- **Closes:** December 23, 2027
- **CFDA:** 93.838, 93.233, 93.839, 93.855, 93.837
- **View on Kontrakk:** https://kontrakk.com/grants/357334

## Description

No description provided.